CBUS vs. AVD, LFVN, CGA, NAII, EVGN, MTEX, BIOX, LWAY, CSV, and LMNR
Should you be buying Cibus stock or one of its competitors? The main competitors of Cibus include American Vanguard (AVD), LifeVantage (LFVN), China Green Agriculture (CGA), Natural Alternatives International (NAII), Evogene (EVGN), Mannatech (MTEX), Bioceres Crop Solutions (BIOX), Lifeway Foods (LWAY), Carriage Services (CSV), and Limoneira (LMNR).
Cibus (NASDAQ:CBUS) and American Vanguard (NYSE:AVD) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, community ranking, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.
In the previous week, Cibus had 1 more articles in the media than American Vanguard. MarketBeat recorded 14 mentions for Cibus and 13 mentions for American Vanguard. American Vanguard's average media sentiment score of 0.27 beat Cibus' score of -0.09 indicating that American Vanguard is being referred to more favorably in the news media.
American Vanguard has a net margin of 1.22% compared to Cibus' net margin of -12,313.28%. American Vanguard's return on equity of 2.20% beat Cibus' return on equity.
American Vanguard has higher revenue and earnings than Cibus. Cibus is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.
Cibus presently has a consensus price target of $25.00, indicating a potential upside of 33.90%. American Vanguard has a consensus price target of $18.00, indicating a potential upside of 99.34%. Given American Vanguard's higher probable upside, analysts plainly believe American Vanguard is more favorable than Cibus.
American Vanguard received 288 more outperform votes than Cibus when rated by MarketBeat users. However, 100.00% of users gave Cibus an outperform vote while only 61.13% of users gave American Vanguard an outperform vote.
33.8% of Cibus shares are held by institutional investors. Comparatively, 79.0% of American Vanguard shares are held by institutional investors. 49.4% of Cibus shares are held by company insiders. Comparatively, 9.3% of American Vanguard shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Cibus has a beta of 1.99, suggesting that its stock price is 99% more volatile than the S&P 500. Comparatively, American Vanguard has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500.
Summary
American Vanguard beats Cibus on 12 of the 17 factors compared between the two stocks.
Get Cibus News Delivered to You Automatically
Sign up to receive the latest news and ratings for CBUS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CBUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
